(NaturalNews) Prozac. Cialis. Cymbalta. If you have a television or read
magazines, you've heard of their drugs. Eli Lilly, out of Indiana, makes
billions of dollars every year off the sale of their patented chemicals,
which are used to suppress the symptoms of disease in the human body.
Founded by a chemist in the late 19th century; today the pharmaceutical
giant has offices in 18 countries, and its products are sold in 125
countries, with revenues exceeding $20 billion annually.
Most of their arsenal is available in other countries for much less money
than it is here in the United States, as is the case with most prescription
medication. The reason, the pharmaceutical industry claims, is that the
health care systems of other countries demands affordable medication, and
they need somebody somewhere to foot the research bill, so they can get the
next patents lined up before others expire, allowing generic versions of
their drugs to become available on the market. That leaves us Americans,
with our broken healthcare system, footing the bill of their continued
We're not only footing the bill, we have to deal with how the pharmaceutical
machine warps the medical system. While historically a trade secret, it is
standard operating procedure for pharmaceutical giants to pay doctors and
other healthcare professionals to promote their drugs. Seducing doctors into
becoming mouthpieces for a share of their bottom line is where it begins,
but it ends up dictating your options.
A history of
Beginning in 2012, all drug and medical device companies will be required to
report their promotional expenditure numbers to the federal government, but
several companies started disclosing their information in 2009. According to
the disclosed information, last year
Eli Lilly paid out
more than $200 million in payments to doctors and healthcare providers for
promoting their drugs. ProPublica.org's Dollars for Docs database is
tracking 11 other companies' disclosures as well.
The reason this information has been disclosed in Eli Lilly's case is
because Eli Lilly was involved in a criminal settlement, and was ordered to
disclose these payments, since 2009. They agreed to pay $1.4 billion to
settle criminal and civil allegations of promoting drugs for unapproved
uses. An official from the FDA testified in a court of law that Eli Lilly
concealed the risks of its schizophrenia drug Zyprexa from U.S. officials,
knowing the serious health risks it caused. They defrauded Medicare/Medicaid
and blatantly put profit over the concern of the consumer.
The disclosure documents say the payments were for speaking, consulting, and
research, as well as travel and meal reimbursement. You can look up the
breakdown of the payments; how much was paid into your state, if your
doctor was among those
paid. The data provides insights into how firms adapt their strategies over
time, even though complete analysis has proved challenging. So few companies
report their data, and the data that is reported is inconsistent in both
content and format. Its unclear exactly how much money is being spent where,
and by whom. Needless to say, there will be more on this story in the
The transparency of the newly required disclosures has some companies
reevaluating the current strategy. Most of the pharmaceutical giants have
begun to reduce their promotional expenditures, since they started
disclosing the figures. Most of them offer explanations such as, "normal
year-to-year fluctuations." Experts predict physicians will begin backing
away from these arrangements as well, as the increased scrutiny of the
pharmaceutical sales practices also exposes their names and pay. Some
doctors are raking in
a quarter of a million dollars, but actually claim they "wouldn't want the
appearance of being influenced by anything the company gave" them.
Interesting choice of words, huh?